• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病与中风风险:一项系统评价方案

Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol.

作者信息

Morgan Ann D, Sharma Chetna, Rothnie Kieran J, Quint Jennifer K

机构信息

Respiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College London, London, UK.

University College London, London, UK.

出版信息

BMJ Open. 2016 Nov 29;6(11):e011898. doi: 10.1136/bmjopen-2016-011898.

DOI:10.1136/bmjopen-2016-011898
PMID:27899397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5168539/
Abstract

INTRODUCTION

There is good evidence to suggest that chronic obstructive pulmonary disease (COPD) increases the risk of ischaemic heart disease, in particular myocardial infarction (MI). The relationship between stroke and COPD, however, is not as well established, and studies conducted to date have generated conflicting results.

METHODS AND ANALYSIS

MEDLINE and Embase will be searched for relevant articles using a prespecified search strategy. We will target observational studies conducted in the general population that employ either a longitudinal cohort or case-control study design to estimate ORs, HRs or incident rate ratios for the association between COPD and a subsequent first stroke. Both stages of screening, title and abstract followed by full-text screening, will be conducted independently by two reviewers. The Population, Exposure, Comparator, Outcomes, Study characteristics (PECOS) framework will be used to systematise the process of extracting data from those studies meeting our selection criteria. Study quality will be assessed using an adapted version of the Newcastle-Ottawa risk of bias tool. The data extraction and the risk of bias assessment will also be conducted in duplicate. A meta-analysis will be considered if there is sufficient homogeneity across selected studies or groups of studies. If a meta-analysis is not justified, a narrative synthesis will be conducted. Selected Grading of Recommendations, Assessment, Development and Evaluation (GRADE) criteria will be used to assess the quality of the cumulative evidence.

DISSEMINATION

Currently ranking second and fourth in the list of global causes of mortality, respectively, stroke and COPD are important non-communicable diseases. With this review, we hope to clarify some of the current uncertainty that surrounds the COPD-stroke relationship and in turn improve understanding of the nature of the role of COPD in comorbid stroke.

PROSPERO REGISTRATION NUMBER

CRD42016035932.

摘要

引言

有充分证据表明,慢性阻塞性肺疾病(COPD)会增加缺血性心脏病的风险,尤其是心肌梗死(MI)。然而,中风与COPD之间的关系尚未明确确立,迄今为止进行的研究结果相互矛盾。

方法与分析

将使用预先指定的检索策略在MEDLINE和Embase中检索相关文章。我们将针对在一般人群中进行的观察性研究,这些研究采用纵向队列或病例对照研究设计,以估计COPD与随后首次中风之间关联的比值比(OR)、风险比(HR)或发病率比。标题和摘要筛选以及全文筛选这两个阶段将由两名评审员独立进行。将使用人群、暴露、对照、结局、研究特征(PECOS)框架来系统化从符合我们选择标准的研究中提取数据的过程。将使用纽卡斯尔-渥太华偏倚风险工具的改编版评估研究质量。数据提取和偏倚风险评估也将重复进行。如果所选研究或研究组之间存在足够的同质性,则将考虑进行荟萃分析。如果荟萃分析不合理,则将进行叙述性综合分析。将使用推荐分级、评估、制定和评价(GRADE)标准的选定标准来评估累积证据的质量。

传播

中风和COPD分别是目前全球死亡率排名第二和第四的重要非传染性疾病。通过本综述,我们希望澄清目前围绕COPD与中风关系的一些不确定性,进而增进对COPD在合并中风中作用性质的理解。

PROSPERO注册号:CRD42016035932。

相似文献

1
Chronic obstructive pulmonary disease and the risk of stroke: a systematic review protocol.慢性阻塞性肺疾病与中风风险:一项系统评价方案
BMJ Open. 2016 Nov 29;6(11):e011898. doi: 10.1136/bmjopen-2016-011898.
2
Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol.伴有 COPD 和心力衰竭的合并症患者的住院和死亡结局:系统评价方案。
BMJ Open. 2018 Jun 30;8(6):e023058. doi: 10.1136/bmjopen-2018-023058.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Quality of aerobic training description and its relation to intervention efficacy in chronic obstructive pulmonary disease trials: study protocol for a systematic review, meta-analysis and meta-regression.有氧运动训练描述的质量及其与慢性阻塞性肺疾病试验干预效果的关系:系统评价、荟萃分析和荟萃回归的研究方案。
BMJ Open. 2024 May 24;14(5):e084296. doi: 10.1136/bmjopen-2024-084296.
5
Epidemiology of chronic obstructive pulmonary disease in the global HIV-infected population: a systematic review and meta-analysis protocol.全球感染艾滋病毒人群中慢性阻塞性肺疾病的流行病学:一项系统评价和荟萃分析方案
Syst Rev. 2017 Mar 29;6(1):68. doi: 10.1186/s13643-017-0467-x.
6
Psychological therapies for the treatment of depression in chronic obstructive pulmonary disease.用于治疗慢性阻塞性肺疾病中抑郁症的心理疗法。
Cochrane Database Syst Rev. 2019 Mar 6;3(3):CD012347. doi: 10.1002/14651858.CD012347.pub2.
7
Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.慢性阻塞性肺疾病(COPD)患者发生心肌梗死(MI)的风险及MI后的死亡风险:一项系统评价和荟萃分析。
BMJ Open. 2015 Sep 11;5(9):e007824. doi: 10.1136/bmjopen-2015-007824.
8
Safety and efficacy of inpatient pulmonary rehabilitation for patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease: a systematic review protocol.住院肺康复治疗慢性阻塞性肺疾病急性加重患者的安全性和有效性的系统评价方案。
BMJ Open. 2021 Jun 23;11(6):e043377. doi: 10.1136/bmjopen-2020-043377.
9
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.针对患有慢性阻塞性肺疾病和至少一种其他长期疾病的成年人的定制或改编干预措施:一项混合方法综述。
Cochrane Database Syst Rev. 2021 Jul 26;7(7):CD013384. doi: 10.1002/14651858.CD013384.pub2.
10
Telehealth for patients with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis protocol.慢性阻塞性肺疾病(COPD)患者的远程医疗:一项系统评价和荟萃分析方案
BMJ Open. 2018 Sep 19;8(9):e021865. doi: 10.1136/bmjopen-2018-021865.

引用本文的文献

1
Hospitalisation and mortality in patients with comorbid COPD and heart failure: a systematic review and meta-analysis.合并 COPD 和心力衰竭患者的住院和死亡率:系统评价和荟萃分析。
Respir Res. 2020 Feb 14;21(1):54. doi: 10.1186/s12931-020-1312-7.
2
Associations between multimorbidity, all-cause mortality and glycaemia in people with type 2 diabetes: A systematic review.2 型糖尿病患者的共病、全因死亡率与血糖之间的关联:系统综述。
PLoS One. 2018 Dec 26;13(12):e0209585. doi: 10.1371/journal.pone.0209585. eCollection 2018.
3
Hospitalisation and mortality outcomes of patients with comorbid COPD and heart failure: a systematic review protocol.伴有 COPD 和心力衰竭的合并症患者的住院和死亡结局:系统评价方案。
BMJ Open. 2018 Jun 30;8(6):e023058. doi: 10.1136/bmjopen-2018-023058.
4
Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.保加利亚人群慢性阻塞性肺疾病治疗的真实生活评估:一项为期1年的前瞻性、观察性、非干预性研究。
Int J Chron Obstruct Pulmon Dis. 2018 Feb 22;13:653-663. doi: 10.2147/COPD.S153969. eCollection 2018.
5
Chronic Obstructive Pulmonary Disease and the Risk of Stroke.慢性阻塞性肺疾病与中风风险。
Ann Am Thorac Soc. 2017 May;14(5):754-765. doi: 10.1513/AnnalsATS.201611-932SR.

本文引用的文献

1
Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.慢性阻塞性肺疾病(COPD)患者发生心肌梗死(MI)的风险及MI后的死亡风险:一项系统评价和荟萃分析。
BMJ Open. 2015 Sep 11;5(9):e007824. doi: 10.1136/bmjopen-2015-007824.
2
Chronic obstructive pulmonary disease and cerebrovascular disease: A comprehensive review.慢性阻塞性肺疾病与脑血管疾病:综述
Respir Med. 2015 Nov;109(11):1371-80. doi: 10.1016/j.rmed.2015.07.014. Epub 2015 Jul 26.
3
Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.慢性阻塞性肺疾病患者心血管合并症的风险:系统评价和荟萃分析。
Lancet Respir Med. 2015 Aug;3(8):631-9. doi: 10.1016/S2213-2600(15)00241-6. Epub 2015 Jul 22.
4
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.系统评价和荟萃分析议定书的首选报告项目(PRISMA-P)2015:详细说明和解释。
BMJ. 2015 Jan 2;350:g7647. doi: 10.1136/bmj.g7647.
5
Chronic obstructive pulmonary disease and cardiovascular disease.慢性阻塞性肺疾病与心血管疾病。
Transl Res. 2013 Oct;162(4):237-51. doi: 10.1016/j.trsl.2013.05.001. Epub 2013 May 31.
6
Cardiovascular comorbidity in COPD: systematic literature review.COPD 中的心血管合并症:系统文献回顾。
Chest. 2013 Oct;144(4):1163-1178. doi: 10.1378/chest.12-2847.
7
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.基于验证性客观测量和全身炎症的慢性阻塞性肺疾病患者的共病群。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.
8
Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的合并症与死亡率风险。
Am J Respir Crit Care Med. 2012 Jul 15;186(2):155-61. doi: 10.1164/rccm.201201-0034OC. Epub 2012 May 3.
9
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease.神经和内分泌紊乱:慢性阻塞性肺疾病中的孤儿。
Respir Med. 2011 Oct;105 Suppl 1:S12-9. doi: 10.1016/S0954-6111(11)70005-1.
10
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.在初级保健中使用数据的综合分析:COPD 患者主要合并症的患病率与心肌梗死和中风的发生率。
Thorax. 2010 Nov;65(11):956-62. doi: 10.1136/thx.2009.128082. Epub 2010 Sep 25.